2 withdrawn, 1 completed, 1 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
| Phase 4 | 1 | Completed 1 |
Follow UPA: new trials by email Literature Review of UPA trials Research Report on UPA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of the Unified Protocol for the Transdiagnostic Treatment (UP-A; Ehrenreich-May et al., 2018) for Adolescents With Moderate Emotional Symptoms in Educational Settings UPA, Active control condition (Progressive Relaxation Training) - Anxiety Disorder, Depressive Disorder | Not applicable | Unknown | Eduardo Fonseca Pedrero | 300 | 2021-12-01 | 2022-04-13 |
| Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding UPA, TEA, Placebo (for UPA) - Heavy Menstrual Bleeding | Phase 1 | Withdrawn | University of Saskatchewan | 2020-01-01 | 2020-01-28 | |
| Impact of Combined Hormonal Contraceptives on UPA Ulipristal Acetate, Levonorgestrel (LNG)/Ethinyl estradiol birth control pill - Contraception | Phase 4 | Completed | Oregon Health and Science University | 36 | 2015-09-08 | 2019-11-08 |
| Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma Ulipristal Acetate, Iron - Leiomyomas | Phase 3 | Withdrawn | Watson Pharmaceuticals | 2012-04-01 | 2013-02-07 |
Anxiety Disorders (1) · Depression (1) · Depressive Disorder (1) · Leiomyoma (1) · Menorrhagia (1)
Eduardo Fonseca Pedrero (1) · Oregon Health and Science University (1) · University of Saskatchewan (1) · Watson Pharmaceuticals (1)
United States (2) · Canada (1) · Spain (1)
Alison Edelman, MD (1) · Almereau Prollius, MD (1) · Eduardo Fonseca Pedrero, PhD (1) · Howard Zobrist, MS, PhD (1)